12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
The article highlights significant intraday movements in health care stocks on Thursday. Notable gainers include Virax Biolabs Group (VRAX), FibroBiologics (FBLG), Aethlon Medical (AEMD), American Oncology Network (AONC), Replimune Group (REPL), and Co-Diagnostics (CODX). On the losing side, Ventyx Biosciences (VTYX), Fresh2 Group (FRES), ENDRA Life Sciences (NDRA), Kineta (KA), 4D Molecular Therapeutics (FDMT), and Akso Health Group (AHG) saw declines.
June 06, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aethlon Medical stock rose 39.58% to $0.61, increasing its market cap to $3.1 million.
The sharp rise in stock price suggests positive news or investor sentiment.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
American Oncology Network stock rose 32.96% to $3.0, raising its market cap to $30.6 million.
The significant price increase indicates strong market interest or positive news.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Co-Diagnostics stock rose 27.18% to $1.31, increasing its market cap to $40.9 million.
The sharp rise in stock price suggests positive news or investor sentiment.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
FibroBiologics shares rose 45.37% to $9.74, boosting its market cap to $318.6 million.
The significant price increase indicates strong market interest or positive developments.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Replimune Group shares rose 29.04% to $7.17, boosting its market cap to $440.6 million.
The substantial price increase suggests strong positive sentiment or news driving the stock higher.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Virax Biolabs Group shares rose 88.8% to $2.02, significantly increasing its market cap to $4.7 million.
The substantial price increase suggests strong positive sentiment or news driving the stock higher.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Akso Health Group stock declined by 14.42% to $0.89, reducing its market cap to $130.5 million.
The sharp decline in stock price suggests negative news or investor sentiment.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
4D Molecular Therapeutics shares decreased by 17.34% to $22.55, reducing its market cap to $1.1 billion.
The significant price drop indicates negative news or investor sentiment.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Fresh2 Group stock decreased by 23.15% to $0.47, reducing its market cap to $11.4 million.
The significant price drop suggests negative news or investor sentiment.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Kineta shares decreased by 19.3% to $0.5, reducing its market cap to $6.1 million.
The sharp decline in stock price suggests negative news or investor sentiment.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
ENDRA Life Sciences stock declined by 19.95% to $0.11, reducing its market cap to $1.2 million.
The sharp decline in stock price indicates negative news or investor sentiment.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Ventyx Biosciences stock fell 37.9% to $3.28, reducing its market cap to $231.2 million.
The significant price drop indicates negative news or investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100